Buzzing Politics
  • News
  • Privacy Policy
  • Terms of Use
  • Disclaimer
Select Page
American Eagle Likely To Report Higher Q4 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

American Eagle Likely To Report Higher Q4 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

by Avi Kapoor | Mar 4, 2026 | General

American Eagle Outfitters, Inc. (NYSE:AEO) will release earnings results for its fourth quarter, after the closing bell on Wednesday, March 4. Analysts expect the Pittsburgh, Pennsylvania-based company to report quarterly earnings at 72 cents per share, up from 54...

China’s Auto Paradox: Why 30 Million Cars A Year Isn’t Enough To Beat Toyota’s Bottom Line

by Stjepan Kalinic | Mar 4, 2026 | General

According to Wei Jianjun, chairman of Great Wall Motors (OTCPK: GWLLF), the gap between Chinese cars and those from Europe, America, Japan, and South Korea is still “very large.” Jianjun’s remark goes against the prevailing narrative of unqualified triumph...

SSR Mining Stock Soars After $1.5 Billion Asset Sale Deal

by Lekha Gupta | Mar 4, 2026 | General

SSR Mining Inc. (NASDAQ:SSRM) shares surged Wednesday after the company agreed to sell its 80% stake in the Çöpler Mine in Türkiye to Cengiz Holding A.S. for $1.5 billion in cash. Cengiz Holding will pay a $100 million deposit, credited toward the purchase price at...
BitMine Immersion Technologies Stock Surges Wednesday: What’s Driving The Action?

BitMine Immersion Technologies Stock Surges Wednesday: What’s Driving The Action?

by Henry Khederian | Mar 4, 2026 | General

BitMine Immersion Technologies Inc (NYSE:BMNR) is trading higher Wednesday morning as cryptocurrencies rally, with Ethereum (CRYPTO: ETH) up about 5% to roughly $2,100. Here’s what investors need to know. BitMine Immersion shares are climbing with conviction. Why are...

Micro-Cap Can-Fite BioPharma Shares Surge On Successful Pancreatic Cancer Drug Study

by Vandana Singh | Mar 4, 2026 | General

Can-Fite BioPharma Ltd. (AMEX:CANF) shares are up on Wednesday following the company’s announcement that its drug, Namodenoson, successfully met the primary endpoint in a Phase 2a study for pretreated pancreatic cancer patients. Can-Fite BioPharma’s Pancreatic Cancer...
« Older Entries
Next Entries »

Recent Posts

  • What’s Going On With Nike Stock Today?
  • Bitcoin, Ethereum, XRP, Dogecoin Up 5% After Trump Signals Iran Conflict De-Escalation
  • EXCLUSIVE: Pineapple Financial Plans AI Push In Restructuring To Boost Growth, $2.5 Million Cost Cuts
  • Apollo Moves Into U.K. Retirement Market With New Global Credit Fund
  • Will Trump Cripple Iran’s Oil Exports By Targeting Kharg Island?

Recent Comments

    Archives

    • March 2026
    • February 2026
    • January 2026
    • December 2025
    • November 2025
    • October 2025
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • October 2019
    • September 2019
    • August 2019
    • July 2019
    • June 2019

    Categories

    • Breaking
    • Business
    • Daily
    • General
    • Markets
    • News
    • Reports
    • Technology

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    • News
    • Privacy Policy
    • Terms of Use
    • Disclaimer
    Copyright 2019 Karmaholic Media LLC. All Rights Reserved.